The current commonly used screening methods for HCC include the alpha-fetoprotein (AFP) diagnostic marker, ultrasonography, computed tomography, magnetic resonance imaging and liver biopsy [150]. This evidence concerns the gene AFP and hepatocellular carcinoma.